Transplantation of neural stem cells (NSCs) improves functional outcomes following traumatic brain injury (TBI). Previously we demonstrated that human NSCs (hNSCs) via releasing glial cell line-derived neurotrophic factor (GDNF), preserved cognitive function in rats following parasagittal fluid percussion. However, the underlying mechanisms remain elusive. In this study, we report that NSC grafts significantly reduce TBI-induced axonal injury in the fimbria and other brain regions by blocking abnormal accumulation of amyloid precursor protein (APP). A preliminary mass spectrometry proteomics study revealed the opposite effects of TBI and NSCs on many of the cytoskeletal proteins in the CA3 region of the hippocampus, including α-smooth muscle actin (α-SMA), the main stress fiber component. Further, Western blot and immunostaining studies confirmed that TBI significantly increased the expression of α-SMA in hippocampal neurons, whereas NSC grafts counteracted the effect of TBI. In an in vitro model, rapid stretch injury significantly shortened lengths of axons and dendrites, increased the expression of both APP and α-SMA, and induced actin aggregation, effects offset by GDNF treatment. These GDNF protective effects were reversed by a GDNF-neutralizing antibody or a specific calcineurin inhibitor, and were mimicked by a specific Rho inhibitor. In summary, we demonstrate for the first time that hNSC grafts and treatment with GDNF acutely reduce traumatic axonal injury and promote neurite outgrowth. Possible mechanisms underlying GDNF-mediated neurite protection include balancing the activity of calcineurin, whereas GDNF-induced neurite outgrowth may result from the reduction of the abnormal α-SMA expression and actin aggregation via blocking Rho signals. Our study also suggests the necessity of further exploring the roles of α-SMA in the central nervous system (CNS), which may lead to a new avenue to facilitate recovery after TBI and other injuries.
Get full access to this article
View all access options for this article.
References
1.
AdamsJ.H., GrahamD.I., GennarelliT.A., MaxwellW.L.1991. Diffuse axonal injury in non-missile head injury. J. Neurol. Neurosurg. Psychiatry, 54:481–483.
2.
AkerudP., AlberchJ., EketjallS., WagnerJ., ArenasE.1999. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J. Neurochem., 73:70–78.
3.
AlN.F., WennerstenA., HolminS., MeijerX., WahlbergL., MathiesenT.2004. MHC expression after human neural stem cell transplantation to brain contused rats. Neuroreport, 15:1871–1875.
4.
BackS., HaasP., TschapeJ.A., GrueblT., KirschJ., MullerU., BeyreutherK., KinsS.2007. beta-amyloid precursor protein can be transported independent of any sorting signal to the axonal and dendritic compartment. J. Neurosci. Res., 85:2580–2590.
5.
BakshiA., ShimizuS., KeckC.A., ChoS., LeBoldD.G., MoralesD., ArenasE., SnyderE.Y., WatsonD.J., McIntoshT.K.2006. Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury. Eur. J. Neurosci., 23:2119–2134.
6.
BalesJ.W., MaX., YanH.Q., JenkinsL.W., DixonC.E.2010a. Expression of protein phosphatase 2B (calcineurin) subunit A isoforms in rat hippocampus after traumatic brain injury. J. Neurotrauma, 27:109–120.
7.
BalesJ.W., MaX., YanH.Q., JenkinsL.W., DixonC.E.2010b. Regional calcineurin subunit B isoform expression in rat hippocampus following a traumatic brain injury. Brain Res., 1358:211–220.
8.
BatchelorP.E., PorrittM.J., MartinelloP., ParishC.L., LiberatoreG.T., DonnanG.A., HowellsD.W.2002. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol. Cell Neurosci., 21:436–453.
9.
BeckK.D., ValverdeJ., AlexiT., PoulsenK., MoffatB., VandlenR.A., RosenthalA., HeftiF.1995. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature, 373:339–341.
10.
BondeC., KristensenB.W., BlaabjergM., JohansenT.E., ZimmerJ., MeyerM.2000. GDNF and neublastin protect against NMDA-induced excitotoxicity in hippocampal slice cultures. Neuroreport, 11:4069–4073.
BramlettH.M., KraydiehS., GreenE.J., DietrichW.D.1997. Temporal and regional patterns of axonal damage following traumatic brain injury: a beta-amyloid precursor protein immunocytochemical study in rats. J. Neuropathol. Exp. Neurol., 56:1132–1141.
14.
BrodhunM., BauerR., PattS.2004. Potential stem cell therapy and application in neurotrauma. Exp. Toxicol. Pathol., 56:103–112.
15.
BukiA., OkonkwoD.O., PovlishockJ.T.1999. Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. J. Neurotrauma, 16:511–521.
16.
ChaponnierC., GabbianiG.2004. Pathological situations characterized by altered actin isoform expression. J. Pathol., 204:386–395.
17.
CiallellaJ.R., IkonomovicM.D., PaljugW.R., WilburY.I., DixonC.E., KochanekP.M., MarionD.W., DeKoskyS.T.2002. Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J. Neurotrauma, 19:1555–1567.
18.
ConsalesC., VolpicelliF., GrecoD., LeoneL., Colucci-D'AmatoL., Perrone-CapanoC., di PorzioU.2007. GDNF signaling in embryonic midbrain neurons in vitro. Brain Res., 1159:28–39.
19.
CoulpierM., IbanezC.F.2004. Retrograde propagation of GDNF-mediated signals in sympathetic neurons. Mol. Cell Neurosci., 27:132–139.
20.
EllisE.F., McKinneyJ.S., WilloughbyK.A., LiangS., PovlishockJ.T.1995. A new model for rapid stretch-induced injury of cells in culture: characterization of the model using astrocytes. J. Neurotrauma, 12:325–339.
21.
ErbD.E., PovlishockJ.T.1991. Neuroplasticity following traumatic brain injury: a study of GABAergic terminal loss and recovery in the cat dorsal lateral vestibular nucleus. Exp. Brain Res., 83:253–267.
22.
GaoJ., ProughD.S., McAdooD.J., GradyJ.J., ParsleyM.O., MaL., TarensenkoY.I., WuP.2006. Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. Exp. Neurol., 201:281–292.
23.
GeddesJ.F., WhitwellH.L., GrahamD.I.2000. Traumatic axonal injury: practical issues for diagnosis in medicolegal cases. Neuropathol. Appl. Neurobiol., 26:105–116.
24.
GentlemanS.M., NashM.J., SweetingC.J., GrahamD.I., RobertsG.W.1993. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett., 160:139–144.
25.
GerlaiR., McNamaraA., Choi–LundbergD.L., ArmaniniM., RossJ., Powell–BraxtonL., PhillipsH.S.2001. Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur. J. Neurosci., 14:1153–1163.
26.
GoffinJ.M., PittetP., CsucsG., LussiJ.W., MeisterJ.J., HinzB.2006. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J. Cell Biol., 172:259–268.
27.
GraefI.A., WangF., CharronF., ChenL., NeilsonJ., Tessier–LavigneM., CrabtreeG.R.2003. Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell, 113:657–670.
28.
GreerJ.E., McGinnM.J., PovlishockJ.T.2011. Diffuse traumatic axonal injury in the mouse induces atrophy, c-Jun activation, and axonal outgrowth in the axotomized neuronal population. J. Neurosci., 31:5089–5105.
HaganM., WennerstenA., MeijerX., HolminS., WahlbergL., MathiesenT.2003. Neuroprotection by human neural progenitor cells after experimental contusion in rats. Neurosci. Lett., 351:149–152.
31.
HartingM.T., JimenezF., XueH., FischerU.M., BaumgartnerJ., DashP.K., CoxC.S.2009a. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J. Neurosurg., 110:1189–1197.
32.
HartingM.T., SloanL.E., JimenezF., BaumgartnerJ., CoxC.S.Jr.2009b. Subacute neural stem cell therapy for traumatic brain injury. J. Surg. Res., 153:188–194.
33.
HausenloyD.J., OngS.B., YellonD.M.2009. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res. Cardiol., 104:189–202.
34.
HendersonC.E., PhillipsH.S., PollockR.A., DaviesA.M., LemeulleC., ArmaniniM., SimmonsL., MoffetB., VandlenR.A., SimpsonL.C.1994. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science, 266:1062–1064.
HoaneM.R., BecerraG.D., ShankJ.E., TatkoL., PakE.S., SmithM., MurashovA.K.2004. Transplantation of neuronal and glial precursors dramatically improves sensorimotor function but not cognitive function in the traumatically injured brain. J. Neurotrauma, 21:163–174.
37.
HurleyR.A., McGowanJ.C., ArfanakisK., TaberK.H.2004. Traumatic axonal injury: novel insights into evolution and identification. J. Neuropsychiatry Clin. Neurosci., 16:1–7.
38.
KangJ., LemaireH.G., UnterbeckA., SalbaumJ.M., MastersC.L., GrzeschikK.H., MulthaupG., BeyreutherK., Muller–HillB.1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325:733–736.
KimB.T., RaoV.L., SailorK.A., BowenK.K., DempseyR.J.2001. Protective effects of glial cell line-derived neurotrophic factor on hippocampal neurons after traumatic brain injury in rats. J. Neurosurg., 95:674–679.
41.
KimH.J., LeeJ.H., KimS.H.2010. Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis. J. Neurotrauma, 27:131–138.
42.
KitagawaH., SasakiC., SakaiK., MoriA., MitsumotoY., MoriT., FukuchiY., SetoguchiY., AbeK.1999. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab, 19:1336–1344.
43.
KooE.H., SisodiaS.S., ArcherD.R., MartinL.J., WeidemannA., BeyreutherK., FischerP., MastersC.L., PriceD.L.1990. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. U. S. A., 87:1561–1565.
44.
KulbatskiI., MotheA.J., NomuraH., TatorC.H.2005. Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma. Curr. Drug Targets., 6:111–126.
45.
KurzJ.E., HammR.J., SingletonR.H., PovlishockJ.T., ChurnS.B.2005. A persistent change in subcellular distribution of calcineurin following fluid percussion injury in the rat. Brain Res., 1048:153–160.
46.
LannerJ.T., GeorgiouD.K., JoshiA.D., HamiltonS.L.2010. Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb. Perspect. Biol., 2:a003996.
47.
LeeJ.I., AhnnJ.2004. Calcineurin in animal behavior. Mol. Cells, 17:390–396.
48.
LinL.F., DohertyD.H., LileJ.D., BekteshS., CollinsF.1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260:1130–1132.
49.
LonghiL., ZanierE.R., RoyoN., StocchettiN., McIntoshT.K.2005. Stem cell transplantation as a therapeutic strategy for traumatic brain injury. Transpl. Immunol., 15:143–148.
50.
LuD., LiY., WangL., ChenJ., MahmoodA., ChoppM.2001. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J. Neurotrauma, 18:813–819.
51.
MackayD.J., NobesC.D., HallA.1995. The Rho's progress: a potential role during neuritogenesis for the Rho family of GTPases. Trends Neurosci., 18:496–501.
52.
MahmoodA., LuD., QuC., GoussevA., ChoppM.2007. Treatment of traumatic brain injury with a combination therapy of marrow stromal cells and atorvastatin in rats. Neurosurgery, 60:546–553.
53.
MahmoodA., LuD., YiL., ChenJ.L., ChoppM.2001. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J. Neurosurg., 94:589–595.
54.
MansuyI.M.2003. Calcineurin in memory and bidirectional plasticity. Biochem. Biophys. Res. Commun., 311:1195–1208.
55.
MarmarouC.R., PovlishockJ.T.2006. Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury. Exp. Neurol., 197:353–362.
56.
MaxwellW.L., PovlishockJ.T., GrahamD.L.1997. A mechanistic analysis of nondisruptive axonal injury: a review. J. Neurotrauma, 14:419–440.
57.
McGeeA.W., StrittmatterS.M.2003. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci., 26:193–198.
58.
MinnichJ.E., MannS.L., StockM., StolzenbachK.A., MortellB.M., SoderstromK.E., BohnM.C., KozlowskiD.A.2010. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury. Restor. Neurol. Neurosci., 28:293–309.
59.
MiyazakiH., NagashimaK., OkumaY., NomuraY.2001. Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats. Brain Res., 922:165–172.
60.
NobesC.D., HallA.1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell, 81:53–62.
61.
OkonkwoD.O., PovlishockJ.T.1999. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J. Cereb. Blood Flow Metab, 19:443–451.
62.
OppenheimR.W., HouenouL.J., JohnsonJ.E., LinL.F., LiL., LoA.C., NewsomeA.L., PrevetteD.M., WangS.1995. Developing motor neurons rescued from programmed and axotomy–induced cell death by GDNF. Nature, 373:344–346.
63.
PertusaM., Garcia–MatasS., MammeriH., AdellA., RodrigoT., MalletJ., CristofolR., SarkisC., SanfeliuC.2008. Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats. Neurobiol. Aging, 29:1366–1379.
PierceJ.E., TrojanowskiJ.Q., GrahamD.I., SmithD.H., McIntoshT.K.1996. Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta–amyloid peptide after experimental brain injury in the rat. J. Neurosci., 16:1083–1090.
RichardsonR.M., SinghA., SunD., FillmoreH.L., DietrichD.W.III, BullockM.R.2010. Stem cell biology in traumatic brain injury: effects of injury and strategies for repair. J. Neurosurg., 112:1125–1138.
68.
RiedelG.1999. If phosphatases go up, memory goes down. Cell Mol. Life Sci., 55:549–553.
69.
RiessP., MolcanyiM., BentzK., MaegeleM., SimanskiC., CarlitscheckC., SchneiderA., HeschelerJ., BouillonB., SchaferU., NeugebauerE.2007. Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. J. Neurotrauma, 24:216–225.
70.
RiessP., ZhangC., SaatmanK.E., LaurerH.L., LonghiL.G., RaghupathiR., LenzlingerP.M., LifshitzJ., BoockvarJ., NeugebauerE., SnyderE.Y., McIntoshT.K.2002. Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery, 51:1043–1052.
71.
SaatmanK.E., GrahamD.I., McIntoshT.K.1998. The neuronal cytoskeleton is at risk after mild and moderate brain injury. J. Neurotrauma, 15:1047–1058.
72.
SauerH., RosenbladC., BjorklundA.1995. Glial cell line–derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6–hydroxydopamine lesion. Proc. Natl. Acad. Sci. U. S. A., 92:8935–8939.
73.
SchaarD.G., SieberB.A., DreyfusC.F., BlackI.B.1993. Regional and cell–specific expression of GDNF in rat brain. Exp. Neurol., 124:368–371.
74.
SchoutenJ.W., FulpC.T., RoyoN.C., SaatmanK.E., WatsonD.J., SnyderE.Y., TrojanowskiJ.Q., ProckopD.J., MaasA.I., McIntoshT.K.2004. A review and rationale for the use of cellular transplantation as a therapeutic strategy for traumatic brain injury. J. Neurotrauma, 21:1501–1538.
SherriffF.E., BridgesL.R., GentlemanS.M., SivaloganathanS., WilsonS.1994. Markers of axonal injury in post mortem human brain. Acta Neuropathol., 88:433–439.
77.
ShindoT., MatsumotoY., WangQ., KawaiN., TamiyaT., NagaoS.2006. Differences in the neuronal stem cells survival, neuronal differentiation and neurological improvement after transplantation of neural stem cells between mild and severe experimental traumatic brain injury. J. Med. Invest., 53:42–51.
78.
SingletonR.H., StoneJ.R., OkonkwoD.O., PellicaneA.J., PovlishockJ.T.2001. The immunophilin ligand FK506 attenuates axonal injury in an impact–acceleration model of traumatic brain injury. J. Neurotrauma, 18:607–614.
79.
SingletonR.H., ZhuJ., StoneJ.R., PovlishockJ.T.2002. Traumatically induced axotomy adjacent to the soma does not result in acute neuronal death. J. Neurosci., 22:791–802.
80.
StaalJ.A., DicksonT.C., GasperiniR., LiuY., FoaL., VickersJ.C.2010. Initial calcium release from intracellular stores followed by calcium dysregulation is linked to secondary axotomy following transient axonal stretch injury. J. Neurochem., 112:1147–1155.
81.
StoneJ.R., SingletonR.H., PovlishockJ.T.2000. Antibodies to the C–terminus of the beta–amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury. Brain Res., 871:288–302.
82.
SvendsenC.N., ter BorgM.G., ArmstrongR.J., RosserA.E., ChandranS., OstenfeldT., CaldwellM.A.1998. A new method for the rapid and long term growth of human neural precursor cells. J. Neurosci. Methods, 85:141–152.
83.
TarasenkoY.I., YuY., JordanP.M., BottensteinJ., WuP.2004. Effect of growth factors on proliferation and phenotypic differentiation of human fetal neural stem cells. J. Neurosci. Res., 78:625–636.
84.
TateM.C., ShearD.A., HoffmanS.W., SteinD.G., ArcherD.R., LaplacaM.C.2002. Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transplant., 11:283–295.
85.
TomacA., LindqvistE., LinL.F., OgrenS.O., YoungD., HofferB.J., OlsonL.1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature, 373:335–339.
86.
WalkerP.A., HartingM.T., JimenezF., ShahS.K., PatiS., DashP.K., CoxC.S.Jr.2010. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB–mediated increase in interleukin–6 production. Stem Cells Dev., 19:867–876.
87.
WangY., LinS.Z., ChiouA.L., WilliamsL.R., HofferB.J.1997. Glial cell line–derived neurotrophic factor protects against ischemia–induced injury in the cerebral cortex. J. Neurosci., 17:4341–4348.
88.
WennerstenA., MeierX., HolminS., WahlbergL., MathiesenT.2004. Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injury. J. Neurosurg., 100:88–96.
89.
WuP., TarasenkoY.I., GuY., HuangL.Y., CoggeshallR.E., YuY.2002. Region–specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat. Neurosci., 5:1271–1278.
